- Record: found
- Abstract: not found
- Article: not found
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
Michel D Ferrari ,
Hans Christoph Diener ,
Xiaoping Ning ,
Maja Galic ,
Joshua M Cohen ,
Ronghua Yang ,
Matthias Mueller ,
Andrew H Ahn ,
Yael Carmeli Schwartz ,
Melissa Grozinski-Wolff ,
Lindsay Janka ,
Messoud Ashina
August 2019
August 2019
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.